Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 18 04:00PM ET
47.83
Dollar change
-0.46
Percentage change
-0.95
%
Index- P/E20.59 EPS (ttm)2.32 Insider Own0.02% Shs Outstand2.50B Perf Week-1.08%
Market Cap119.70B Forward P/E10.09 EPS next Y4.74 Insider Trans0.00% Shs Float2.50B Perf Month3.10%
Income5.84B PEG2.29 EPS next Q0.95 Inst Own9.90% Short Float0.17% Perf Quarter-0.85%
Sales46.56B P/S2.57 EPS this Y-4.92% Inst Trans-1.65% Short Ratio2.52 Perf Half Y-12.30%
Book/sh32.68 P/B1.46 EPS next Y13.58% ROA4.25% Short Interest4.31M Perf Year-0.60%
Cash/sh3.84 P/C12.44 EPS next 5Y9.00% ROE7.22% 52W Range42.63 - 57.82 Perf YTD-3.82%
Dividend Est.2.07 (4.33%) P/FCF12.96 EPS past 5Y2.68% ROI5.86% 52W High-17.28% Beta0.61
Dividend TTM1.90 (3.97%) Quick Ratio0.87 Sales past 5Y2.80% Gross Margin61.77% 52W Low12.20% ATR (14)0.61
Dividend Ex-DateMay 30, 2023 Current Ratio1.27 EPS Y/Y TTM-33.10% Oper. Margin21.32% RSI (14)47.79 Volatility0.88% 1.19%
Employees87994 Debt/Eq0.25 Sales Y/Y TTM3.18% Profit Margin12.54% Recom1.70 Target Price57.38
Option/ShortYes / Yes LT Debt/Eq0.22 EPS Q/Q- Payout39.20% Rel Volume0.52 Prev Close48.29
Sales Surprise- EPS Surprise- Sales Q/Q-13.36% EarningsFeb 01 BMO Avg Volume1.71M Price47.83
SMA20-0.06% SMA50-2.04% SMA200-5.54% Trades Volume887,471 Change-0.95%
Date Action Analyst Rating Change Price Target Change
Jan-23-24Initiated Morgan Stanley Equal-Weight $55
Jan-16-24Resumed UBS Buy
Dec-05-23Downgrade JP Morgan Overweight → Neutral
Oct-30-23Downgrade Stifel Buy → Hold
Sep-06-23Upgrade Berenberg Hold → Buy
Jul-14-23Initiated HSBC Securities Buy
Apr-28-23Downgrade Deutsche Bank Hold → Sell
Mar-27-23Upgrade Barclays Equal Weight → Overweight
Dec-13-22Resumed Morgan Stanley Overweight
Aug-12-22Upgrade Deutsche Bank Sell → Hold
Mar-15-24 03:04PM
01:03PM
Mar-14-24 09:38AM
08:18AM
Mar-13-24 10:25AM
02:00AM Loading…
Mar-11-24 02:00AM
Mar-07-24 05:44PM
02:15PM
01:57PM
Mar-05-24 02:56AM
Mar-04-24 08:28PM
Feb-27-24 05:51PM
06:53AM
Feb-26-24 08:04AM
Feb-24-24 09:51AM
12:45PM Loading…
Feb-23-24 12:45PM
11:59AM
05:43AM
01:00AM
01:00AM
Feb-22-24 11:24PM
01:02PM
Feb-21-24 05:30AM
Feb-20-24 05:41PM
11:28AM
11:13AM
07:17AM
03:42AM
Feb-19-24 12:44PM
Feb-16-24 08:39AM
08:22AM Loading…
08:22AM
07:15AM
07:13AM
01:00AM
12:59AM
Feb-15-24 08:00AM
Feb-12-24 06:27AM
Feb-10-24 08:30AM
Feb-05-24 02:00AM
Feb-03-24 01:53AM
Feb-02-24 10:18AM
Feb-01-24 05:14PM
04:21PM
03:15PM
10:49AM
10:05AM
07:25AM
05:17AM
02:19AM
02:07AM
01:36AM
01:30AM
01:30AM
01:30AM
Jan-31-24 10:20AM
10:05AM
Jan-29-24 06:39AM
01:39AM
Jan-28-24 01:21PM
Jan-25-24 02:49PM
02:34PM
02:30PM
02:29PM
02:26PM
02:26PM
Jan-24-24 02:05AM
Jan-23-24 05:05PM
04:59PM
04:02PM
11:25AM
10:39AM
09:40AM
07:36AM
06:02AM
05:39AM
05:27AM
04:49AM
01:32AM
01:30AM
01:29AM
01:12AM
01:00AM
Jan-22-24 10:12PM
04:22PM
12:08PM
08:30AM
Jan-18-24 08:21AM
Jan-17-24 04:57PM
06:33AM
Jan-16-24 07:43AM
Jan-12-24 09:00AM
Jan-11-24 09:50PM
Jan-10-24 03:02PM
02:56PM
09:13AM
01:00AM
Jan-09-24 01:30AM
Jan-03-24 07:00AM
Jan-02-24 09:53AM
Jan-01-24 09:40AM
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.